Literature DB >> 11376316

Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting.

Y Cottin1, K Rezaizadeh, C Touzery, I Barillot, M Zeller, S Prevot, I L'huillier, O Ressencourt, F André, M Fraison, P Louis, F Brunotte, J E Wolf.   

Abstract

BACKGROUND: The prognostic value of (201)Tl myocardial imaging has been demonstrated in several studies concerning patients with a known significant coronary artery disease. However, the evolution of a coronary stenosis after stenting is difficult to predict. This study was designed to assess the prognostic value of (201)Tl single-photon emission computed tomography (thallium SPECT) perfusion imaging in patients after intracoronary stenting.
METHODS: One hundred fifty-two patients were studied. They were followed up during 40 +/- 13 (mean +/- SD) months after thallium SPECT. Stent-related events were studied after thallium stress testing and included cardiovascular death, myocardial infarction, and revascularization. Stress thallium imaging was performed 5 +/- 2 months after stenting, and ischemia was considered to be present if at least 2 contiguous segments were showing reversible defects.
RESULTS: Only 3 (3%) among the 105 nonischemic patients had major cardiac events during the follow-up versus 13 (28%) of the 47 ischemic patients (P < .001) after thallium SPECT. The relative risk of major cardiac events for patients with significant ischemia was 10.5 compared with nonischemic patients (P < .001). Fourteen (30%) of the ischemic patients and 8 (8%) among the nonischemic patients underwent iterative revascularization (P < .001). Therefore, only 11 (10%) of the nonischemic patients had major cardiac events or revascularization compared with 24 (51%) of the ischemic patients (P < .001).
CONCLUSIONS: Absence of ischemia on thallium SPECT imaging at 5 months after coronary stenting indicates a low risk for cardiovascular events or interventional procedure. These results may have important clinical implications in patient treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376316     DOI: 10.1067/mhj.2001.114970

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

2.  Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.

Authors:  Hyo Eun Park; Bon-Kwon Koo; Kyung-Woo Park; Jin Chul Paeng; Hae-Young Lee; Hyun-Jae Kang; Hyo-Soo Kim
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-07       Impact factor: 2.357

3.  American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI).

Authors:  R Parker Ward; Mouaz H Al-Mallah; Gabriel B Grossman; Christopher L Hansen; Robert C Hendel; Todd C Kerwin; Benjamin D McCallister; Rupa Mehta; Donna M Polk; Peter L Tilkemeier; Aseem Vashist; Kim Allan Williams; David G Wolinsky; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  Prognostic value of stress-gated 99m-technetium SPECT myocardial perfusion imaging: risk stratification of patients with multivessel coronary artery disease and prior coronary revascularization.

Authors:  Tiziano Schepis; Karin Benz; Andreas Haldemann; Philipp A Kaufmann; Christian Schmidhauser; Jürgen Frielingsdorf
Journal:  J Nucl Cardiol       Date:  2013-07-10       Impact factor: 5.952

5.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

6.  Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.

Authors:  Abdou Elhendy; Arend F l Schinkel; Ron T van Domburg; Jeroen J Bax; Roelf Valkema; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

7.  Myocardial Perfusion SPECT Imaging in Patients after Percutaneous Coronary Intervention.

Authors:  Panagiotis Georgoulias; Varvara Valotassiou; Ioannis Tsougos; Nikolaos Demakopoulos
Journal:  Curr Cardiol Rev       Date:  2010-05

8.  Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation.

Authors:  M Bountioukos; A Elhendy; R T van Domburg; A F L Schinkel; J J Bax; B J Krenning; E Biagini; V Rizzello; M L Simoons; D Poldermans
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

9.  Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention.

Authors:  Xiaoli Zhang; Xiujie Liu; Zuo-Xiang He; Rongfang Shi; Minfu Yang; Runlin Gao; Jilin Chen; Yuejin Yang; Wei Fang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-22       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.